Royal Bank of Canada
JBIO

Royal Bank of Canada’s Jade Biosciences JBIO Stock Holding History

Royal Bank of Canada’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Sell
71
-1,420
-95% -$20.6K ﹤0.01% 6824
2025
Q4 		$23K Buy
1,491
+471
+46% +$5.53K ﹤0.01% 5956
2025
Q3 		$9K Sell
1,020
-2,671
-72% -$21.8K ﹤0.01% 6510
2025
Q2 		$37K Buy
3,691
+3,649
+8,688% +$124K ﹤0.01% 6038
2025
Q1 		$3K Buy
42
+34
+425% +$2.99K ﹤0.01% 6464
2024
Q4 		$1K Sell
8
-51
-86% -$4.39K ﹤0.01% 6755
2024
Q3 		$4K Buy
59
+23
+64% +$1.48K ﹤0.01% 6536
2024
Q2 		$2K Buy
36
+28
+350% +$18.6K ﹤0.01% 6708
2024
Q1 		$8K Sell
8
-91
-92% -$69.5K ﹤0.01% 6270
2023
Q4 		$79K Buy
99
+59
+148% +$30.1K ﹤0.01% 5749
2023
Q3 		$19K Buy
40
+15
+60% +$8.12K ﹤0.01% 6190
2023
Q2 		$15K Buy
25
+10
+67% +$6.4K ﹤0.01% 6320
2023
Q1 		$10K Sell
15
-28
-65% -$23.2K ﹤0.01% 6303
2022
Q4 		$44K Buy
43
+30
+231% +$21.8K ﹤0.01% 5955
2022
Q3 		$8K Buy
13
+12
+1,200% +$8.01K ﹤0.01% 6513
2022
Q2 		$1K Sell
1
-22
-96% -$10.5K ﹤0.01% 7086
2022
Q1 		$15K Sell
23
-42
-65% -$16.3K ﹤0.01% 6750
2021
Q4 		$26K Buy
65
+29
+81% +$14.7K ﹤0.01% 6673
2021
Q3 		$27K Buy
+36
New +$20.2K ﹤0.01% 6513

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Royal Bank of Canada's JBIO Position: Q1 2026 in Review

Royal Bank of Canada reduced its Jade Biosciences (JBIO) stake by 95% in Q1 2026, selling an estimated $20.6K and leaving 71 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6824.

Royal Bank of Canada first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $79K in Q4 2023. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Royal Bank of Canada held 71 shares of Jade Biosciences worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 1,420 Jade Biosciences shares in Q1 2026, an estimated $20.6K.
  • Jade Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6824 holding.
  • Royal Bank of Canada first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Jade Biosciences position peaked at $79K in Q4 2023.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.